US Merger & Acquisition SEC Filings — February 23, 2026

24-02-2026

RF Acquisition Corp III filed an 8-K on February 24, 2026 (AccNo: 0001829126-26-001581), disclosing unregistered sales of equity securities under Item 3.02, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details on deal structure, parties involved, valuation, synergies, regulatory pathway, shareholder impact, or market implications are provided. No quantitative metrics, period-over-period comparisons, or scheduled events are mentioned.

24-02-2026

Northern Oil & Gas, Inc. filed an 8-K on 2026-02-24 disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01), alongside creation of a direct financial obligation (Item 2.03) and Regulation FD disclosure (Item 7.01). No quantitative metrics, deal values, parties involved, synergies, or financial impacts are disclosed in the provided filing information. Item 9.01 references financial statements and exhibits, but specifics are NOT_DISCLOSED.

• ·AccNo: 0001193125-26-064523
• ·Filing Size: 338 KB
• ·Event Type: Merger/Acquisition

24-02-2026

Pelican Acquisition Corp filed an 8-K on February 24, 2026 (AccNo: 0001829126-26-001595), disclosing information under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits related to a merger/acquisition event. No specific details on deal structure, parties, valuation, financial terms, or strategic rationale are explicitly stated in the provided filing summary. All quantitative metrics, named entities beyond the filer, and scheduled events are NOT_DISCLOSED.

24-02-2026

Protagenic Therapeutics, Inc. filed an 8-K on February 24, 2026, disclosing entry into a material definitive agreement (Item 1.01) and termination of a prior material definitive agreement (Item 1.02), alongside completion of an acquisition or disposition of assets (Item 2.01) and unregistered sales of equity securities (Item 3.02). Other events are noted under Item 8.01, with financial statements and exhibits provided under Item 9.01. No quantitative financial metrics, deal values, or specific parties are disclosed.

24-02-2026

EQV Ventures Acquisition Corp. filed an 8-K on 2026-02-24 disclosing entry into a material definitive agreement under Item 1.01, likely related to a merger/acquisition, along with unregistered sales of equity securities (Item 3.02), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No specific transaction parties, deal size, valuation, or financial metrics are disclosed in the provided filing summary. This appears to be a standard SPAC business combination announcement without detailed terms.

24-02-2026

INVO Fertility, Inc. filed an 8-K on 2026-02-24 disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01), alongside unregistered sales of equity securities (Item 3.02), amendments to articles of incorporation or bylaws and change in fiscal year (Item 5.03), other events (Item 8.01), and financial statements/exhibits (Item 9.01). This filing signals a completed merger/acquisition transaction, but no specific parties, terms, values, or impacts are disclosed. No quantitative metrics, positive or negative changes, or performance variations are provided.

24-02-2026

Horizon Space Acquisition II Corp. filed an 8-K on 2026-02-24 disclosing entry into a material definitive agreement under Item 1.01, creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, and unregistered sales of equity securities under Item 3.02. Item 8.01 reports other events, with financial statements and exhibits under Item 9.01. No specific deal terms, financial metrics, parties involved, or performance comparisons are disclosed.

• ·AccNo: 0001929980-26-000053
• ·Filing size: 240 KB

24-02-2026

Cohen Circle Acquisition Corp. II filed an 8-K on February 24, 2026 (AccNo: 0001213900-26-019871, Size: 288 KB), disclosing other events under Item 8.01 and financial statements and exhibits under Item 9.01, in connection with a merger/acquisition event. No specific details on deal structure, parties involved, valuation, terms, financial metrics, synergies, regulatory pathway, or shareholder impacts were explicitly stated. Sector not specified, and no quantitative data, comparisons, or scheduled events provided.

24-02-2026

Trailblazer Merger Corp I filed an 8-K on 2026-02-24 (AccNo: 0001213900-26-019945, Size: 334 KB) disclosing Item 5.07 regarding Submission of Matters to a Vote of Security Holders in connection with a Merger/Acquisition event. No specific details on vote results, parties involved, deal structure, financial terms, or metrics are provided. Sector is not specified.

24-02-2026

Cardiff Oncology, Inc. filed an 8-K on 2026-02-24 announcing the completion of an acquisition or disposition of assets under Item 2.01. The filing includes financial statements and exhibits under Item 9.01. No quantitative metrics, deal details, or performance comparisons are disclosed.

24-02-2026

Art Technology Acquisition Corp. filed an 8-K on 2026-02-24 under Item 5.02 disclosing matters related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific names, dates, financial details, transaction information, or quantitative metrics are mentioned in the filing summary. No positive or negative performance indicators, scheduled events, or M&A details are provided.

24-02-2026

PALOMA ACQUISITION CORP I filed an 8-K on 2026-02-24 disclosing entry into a material definitive agreement under Item 1.01, likely related to a merger/acquisition. The filing also covers unregistered sales of equity securities (Item 3.02), departures/elections/appointments of directors/officers and compensatory arrangements (Item 5.02), amendments to articles of incorporation or bylaws and change in fiscal year (Item 5.03), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No specific details on parties, structure, valuation, terms, or metrics are disclosed.

24-02-2026

SPACSphere Acquisition Corp. filed an 8-K on 2026-02-24 under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits), announcing events related to a merger/acquisition. No specific deal terms, parties, valuations, financial metrics, synergies, regulatory pathways, or shareholder impacts were disclosed. No quantitative data, period-over-period comparisons, or scheduled events were mentioned.

24-02-2026

The filer submitted an 8-K on 2026-02-24 (AccNo: 0001477932-26-001011, 289 KB) disclosing under Item 1.01 entry into a Material Definitive Agreement related to a Merger/Acquisition event, with Item 9.01 covering Financial Statements and Exhibits. No specific deal structure, parties, valuation, terms, financial metrics, or other quantitative details are provided in the filing summary. This is purely informational without positive or negative performance indicators.